Price T Rowe Associates Inc Elevance Health, Inc. Transaction History

Price T Rowe Associates Inc

  • $812 Billion
  • Q1 2025

A detailed history of Price T Rowe Associates Inc transactions in Elevance Health, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 9,142,563 shares of ELV stock, worth $3.18 Billion. This represents 0.49% of its overall portfolio holdings.

Number of Shares
9,142,563
Previous 10,618,062 13.9%
Holding current value
$3.18 Billion
Previous $3.92 Billion 1.52%
% of portfolio
0.49%
Previous 0.45%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$365.9 - $436.25 $540 Million - $644 Million
-1,475,499 Reduced 13.9%
9,142,563 $3.98 Billion
Q4 2024

Feb 14, 2025
BUY
$365.96 - $514.62 $170 Million - $239 Million
464,137 Added 4.57%
10,618,062 $3.92 Billion
Q3 2024

Nov 14, 2024
SELL
$500.12 - $562.29 $746 Million - $839 Million
-1,492,601 Reduced 12.82%
10,153,925 $5.28 Billion
Q2 2024

Aug 14, 2024
SELL
$497.49 - $547.8 $36.7 Million - $40.4 Million
-73,734 Reduced 0.63%
11,646,526 $6.31 Billion
Q1 2024

May 15, 2024
SELL
$464.61 - $519.96 $94.5 Million - $106 Million
-203,333 Reduced 1.71%
11,720,260 $6.08 Billion
Q4 2023

Feb 14, 2024
SELL
$433.51 - $488.06 $46.7 Million - $52.6 Million
-107,780 Reduced 0.9%
11,923,593 $5.62 Billion
Q3 2023

Nov 14, 2023
SELL
$414.13 - $475.93 $29.1 Million - $33.4 Million
-70,184 Reduced 0.58%
12,031,373 $5.24 Billion
Q2 2023

Aug 14, 2023
SELL
$436.33 - $496.2 $513 Million - $583 Million
-1,175,613 Reduced 8.85%
12,101,557 $5.38 Billion
Q1 2023

May 15, 2023
BUY
$446.3 - $502.2 $246 Million - $277 Million
551,614 Added 4.33%
13,277,170 $6.1 Billion
Q4 2022

Feb 14, 2023
BUY
$465.23 - $546.77 $921 Million - $1.08 Billion
1,979,665 Added 18.42%
12,725,556 $6.53 Billion
Q3 2022

Nov 14, 2022
BUY
$445.98 - $507.0 $575 Million - $654 Million
1,290,134 Added 13.64%
10,745,891 $4.88 Billion
Q2 2022

Aug 15, 2022
BUY
$444.32 - $529.84 $311 Million - $371 Million
699,906 Added 7.99%
9,455,757 $4.56 Billion
Q1 2022

May 16, 2022
SELL
$428.44 - $502.48 $449 Million - $526 Million
-1,047,018 Reduced 10.68%
8,755,851 $4.3 Billion
Q4 2021

Feb 14, 2022
SELL
$370.08 - $467.67 $7.61 Million - $9.61 Million
-20,557 Reduced 0.21%
9,802,869 $4.54 Billion
Q3 2021

Nov 15, 2021
SELL
$357.51 - $398.13 $850 Million - $946 Million
-2,376,773 Reduced 19.48%
9,823,426 $3.66 Billion
Q2 2021

Aug 16, 2021
SELL
$352.19 - $401.9 $171 Million - $195 Million
-486,365 Reduced 3.83%
12,200,199 $4.66 Billion
Q1 2021

May 17, 2021
BUY
$287.7 - $371.31 $206 Million - $266 Million
715,968 Added 5.98%
12,686,564 $4.55 Billion
Q4 2020

Feb 16, 2021
BUY
$270.17 - $333.15 $3.23 Billion - $3.99 Billion
11,970,596 New
11,970,596 $3.84 Billion

Others Institutions Holding ELV

# of Institutions
1,884
Shares Held
204M
Call Options Held
1.67M
Put Options Held
1.15M
View Full List

About Elevance Health, Inc.

ELV Quotes by TradingView
  • Ticker ELV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 240,000,992
  • Market Cap $83.5B
  • Description
  • Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....
More about ELV
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email